Cargando…

Limiting treatment plan complexity by applying a novel commercial tool

PURPOSE: A recently introduced commercial tool is tested to assess whether it is able to reduce the complexity of a treatment plan and improve deliverability without compromising overall quality. METHODS: Ten prostate and ten oropharynx plans of previously treated patients were reoptimized using the...

Descripción completa

Detalles Bibliográficos
Autores principales: Scaggion, Alessandro, Fusella, Marco, Agnello, Giancarmelo, Bettinelli, Andrea, Pivato, Nicola, Roggio, Antonella, Rossato, Marco A., Sepulcri, Matteo, Paiusco, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484888/
https://www.ncbi.nlm.nih.gov/pubmed/32436656
http://dx.doi.org/10.1002/acm2.12908
_version_ 1783581065216000000
author Scaggion, Alessandro
Fusella, Marco
Agnello, Giancarmelo
Bettinelli, Andrea
Pivato, Nicola
Roggio, Antonella
Rossato, Marco A.
Sepulcri, Matteo
Paiusco, Marta
author_facet Scaggion, Alessandro
Fusella, Marco
Agnello, Giancarmelo
Bettinelli, Andrea
Pivato, Nicola
Roggio, Antonella
Rossato, Marco A.
Sepulcri, Matteo
Paiusco, Marta
author_sort Scaggion, Alessandro
collection PubMed
description PURPOSE: A recently introduced commercial tool is tested to assess whether it is able to reduce the complexity of a treatment plan and improve deliverability without compromising overall quality. METHODS: Ten prostate and ten oropharynx plans of previously treated patients were reoptimized using the aperture shape controller (ASC) tool recently introduced in Eclipse TPS (Varian Medical Systems, Palo Alto, CA). The performance of ASC was assessed in terms of the overall plan quality using a plan quality metric, the reduction in plan complexity through the analysis of 14 of the most common plan complexity metrics, and the change in plan deliverability through 3D dosimetric measurements. Similarly, plans optimized limiting the total number of delivered monitor units was assessed and compared. The two strategies were also combined to assess their potential combination. RESULTS: The plans optimized by exploiting the ASC generally show a reduced number of total Monitor Units, a more constant gantry rotation and a MLC modulation characterized by larger and less complicated shapes with leaves traveling shorter overall lengths. CONCLUSIONS: This first experience suggests that the ASC is an effective tool to reduce the unnecessary complexity of a plan. This turns into an increased plan deliverability with no loss of plan quality.
format Online
Article
Text
id pubmed-7484888
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74848882020-09-18 Limiting treatment plan complexity by applying a novel commercial tool Scaggion, Alessandro Fusella, Marco Agnello, Giancarmelo Bettinelli, Andrea Pivato, Nicola Roggio, Antonella Rossato, Marco A. Sepulcri, Matteo Paiusco, Marta J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: A recently introduced commercial tool is tested to assess whether it is able to reduce the complexity of a treatment plan and improve deliverability without compromising overall quality. METHODS: Ten prostate and ten oropharynx plans of previously treated patients were reoptimized using the aperture shape controller (ASC) tool recently introduced in Eclipse TPS (Varian Medical Systems, Palo Alto, CA). The performance of ASC was assessed in terms of the overall plan quality using a plan quality metric, the reduction in plan complexity through the analysis of 14 of the most common plan complexity metrics, and the change in plan deliverability through 3D dosimetric measurements. Similarly, plans optimized limiting the total number of delivered monitor units was assessed and compared. The two strategies were also combined to assess their potential combination. RESULTS: The plans optimized by exploiting the ASC generally show a reduced number of total Monitor Units, a more constant gantry rotation and a MLC modulation characterized by larger and less complicated shapes with leaves traveling shorter overall lengths. CONCLUSIONS: This first experience suggests that the ASC is an effective tool to reduce the unnecessary complexity of a plan. This turns into an increased plan deliverability with no loss of plan quality. John Wiley and Sons Inc. 2020-05-21 /pmc/articles/PMC7484888/ /pubmed/32436656 http://dx.doi.org/10.1002/acm2.12908 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Scaggion, Alessandro
Fusella, Marco
Agnello, Giancarmelo
Bettinelli, Andrea
Pivato, Nicola
Roggio, Antonella
Rossato, Marco A.
Sepulcri, Matteo
Paiusco, Marta
Limiting treatment plan complexity by applying a novel commercial tool
title Limiting treatment plan complexity by applying a novel commercial tool
title_full Limiting treatment plan complexity by applying a novel commercial tool
title_fullStr Limiting treatment plan complexity by applying a novel commercial tool
title_full_unstemmed Limiting treatment plan complexity by applying a novel commercial tool
title_short Limiting treatment plan complexity by applying a novel commercial tool
title_sort limiting treatment plan complexity by applying a novel commercial tool
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484888/
https://www.ncbi.nlm.nih.gov/pubmed/32436656
http://dx.doi.org/10.1002/acm2.12908
work_keys_str_mv AT scaggionalessandro limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT fusellamarco limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT agnellogiancarmelo limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT bettinelliandrea limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT pivatonicola limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT roggioantonella limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT rossatomarcoa limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT sepulcrimatteo limitingtreatmentplancomplexitybyapplyinganovelcommercialtool
AT paiuscomarta limitingtreatmentplancomplexitybyapplyinganovelcommercialtool